Discovery of C-imidazole azaheptapyridine FPT inhibitors.
Zhu, H.Y., Cooper, A.B., Desai, J., Njoroge, G., Kirschmeier, P., Bishop, W.R., Strickland, C., Hruza, A., Doll, R.J., Girijavallabhan, V.M.(2010) Bioorg Med Chem Lett 20: 1134-1136
- PubMed: 20056542 
- DOI: https://doi.org/10.1016/j.bmcl.2009.12.013
- Primary Citation of Related Structures:  
3KSQ - PubMed Abstract: 
The discovery of C-linked imidazole azaheptapyridine bridgehead FPT inhibitors is described. This novel class of compounds are sub nM FPT enzyme inhibitors with potent cellular inhibitory activities. This series also has reduced hERG activity versus previous N-linked imidazole series. X-ray of compound 10a bound to FTase revealed strong interaction between bridgehead imidazole 3N with catalytic zinc atom.
Organizational Affiliation: 
Schering Plough Research Institute, 2015 Galloping Hill Rd, Kenilworth, NJ 07033, USA. hugh.zhu@spcorp.com